Ensartinib
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 151 publications
Ensartinib Combined with Radiotherapy for the Treatment of Advanced Primary Pulmonary Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring TPM3-ALK Fusion: A Case Report
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: March 04, 2026
Cost of managing brain metastases in ALK-positive advanced NSCLC patients receiving first-line ALK TKIs in China.
Journal: Lung cancer management
Published: February 03, 2026
Efficacy and safety of ensartinib in the treatment of non-small cell lung cancer: A systematic review of clinical trials.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: October 28, 2025
Breaking resistance barriers: ensartinib as a milestone in anaplastic lymphoma kinase-driven non-small cell lung cancer therapy.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: October 01, 2025
Treatment with ensartinib improves postoperative survival in a patient with stage IIB LUAD carrying a rare ALK mutation: case report.
Journal: Open life sciences
Published: September 09, 2025
Comparative analysis of ctDNA monitoring strategies in advanced NSCLC with MET exon 14 skipping mutations treated with ensartinib.
Journal: NPJ precision oncology
Published: August 29, 2025
Comparison of the efficacy based on clinicopathological characteristics and the safety of first-line treatments for patients with advanced ALK rearrangement non-small cell lung cancer: a network meta-analysis.
Journal: Frontiers in oncology
Published: August 01, 2025
Patient-derived organoid facilitating personalized medicine in non-small cell lung cancer: two case reports.
Journal: Frontiers in oncology
Published: July 28, 2025
Severe skin toxicity and early progression following neoadjuvant ensartinib and surgery in anaplastic lymphoma kinase-positive locally advanced lung cancer: a case report.
Journal: Frontiers in pharmacology
Published: July 25, 2025
Ensartinib targeted conversion surgery for ALK-positive unresectable locally advanced non-small cell lung cancer: a case report.
Journal: Journal of cardiothoracic surgery
Published: July 02, 2025
Amylase-producing lung adenocarcinoma with an anaplastic lymphoma kinase fusion mutation: a case report.
Journal: Laboratory medicine
Published: June 25, 2025
Last Updated: 04/28/2026